CytomX Therapeutics, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CytomX Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • CytomX Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -27.4 %, a 155% decline year-over-year.
  • CytomX Therapeutics, Inc. annual Return On Equity for 2023 was 0.84 %, a 99.5% decline from 2022.
  • CytomX Therapeutics, Inc. annual Return On Equity for 2022 was 159 %.
  • CytomX Therapeutics, Inc. annual Return On Equity for 2021 was -275 %, a 78.9% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 0.84 -158 -99.5% Jan 1, 2023 Dec 31, 2023
2022 159 +433 Jan 1, 2022 Dec 31, 2022
2021 -275 -121 -78.9% Jan 1, 2021 Dec 31, 2021
2020 -154 +6.67 +4.16% Jan 1, 2020 Dec 31, 2020
2019 -160 -72.1 -81.9% Jan 1, 2019 Dec 31, 2019
2018 -88.1 -16.7 -23.3% Jan 1, 2018 Dec 31, 2018
2017 -71.4 -9.71 -15.7% Jan 1, 2017 Dec 31, 2017
2016 -61.7 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.